[Problems raised by corticoid therapy in children].
D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use; D000311:Adrenal Glands / Q000187:drug effects; D000309:Adrenal Insufficiency / Q000139:chemically induced / Q000188:drug therapy; D000367:Age Factors; D000818:Animals; D002644:Chickenpox / Q000150:complications; D002648:Child; D003920:Diabetes Mellitus / Q000139:chemically induced; D005260:Female; D006130:Growth Disorders / Q000139:chemically induced; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007031:Hypothalamus / Q000187:drug effects; D009135:Muscular Diseases / Q000139:chemically induced; D009404:Nephrotic Syndrome / Q000188:drug therapy; D009765:Obesity / Q000139:chemically induced; D010024:Osteoporosis / Q000139:chemically induced; D010902:Pituitary Gland / Q000187:drug effects; D011241:Prednisone / Q000494:pharmacology; D011247:Pregnancy; D011559:Pseudotumor Cerebri / Q000139:chemically induced; D011817:Rabbits; D051381:Rats
D000305:Adrenal Cortex Hormones; D011241:Prednisone; D006854:Hydrocortisone
Problèmes posés par la corticothérapie chez l'enfant